Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.

Archive ouverte

Muller, Danièle | Millon, Régine | Théobald, Serge | Hussenet, Thomas | Wasylyk, Bohdan | Du Manoir, Stanislas | Abecassis, Joseph

Edité par CCSD ; Cancer Research UK -

International audience. We evaluated the expression and amplification of cyclin L1 (CCNL1) gene, a potential oncogene localised in the commonly amplified 3q25-28 region, in human head and neck squamous cell carcinomas (HNSCCs). Overexpression was observed in 55 out of 96 cases (57%) and amplification in nine out of 35 tumours (26%) with no relationships to the clinico-pathological parameters. The Cyclin L1 antibody we developed labels nuclear speckles in tumour cells compatible with a role for CCNL1 in RNA splicing.

Consulter en ligne

Suggestions

Du même auteur

Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer

Archive ouverte | Redon, Richard | CCSD

International audience. DNA gains targeting the 3q chromosome are common in head and neck squamous cell carcinomas, as well as in lung, ovarian, and cervical cancer. Several candidate oncogenes located on 3q were pr...

Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis

Archive ouverte | Cromer, Anne | CCSD

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer among men in the developed world. There is a need, for both clinical and scientific reasons, to find markers to identify patients with aggressive diseas...

Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance

Archive ouverte | Millon, Régine | CCSD

The transforming potential of the MDM2 oncogene has been attributed to the overproduction of the protein. In order to investigate regulation of MDM2 expression in head and neck squamous cell carcinomas, we analysed MDM2 gene ampli...

Chargement des enrichissements...